Articles From: - Marsh Executes on Commitment to Rapid Expansion of Marsh Analytics Platform to - NuVasive to Host Investor Morning on November 13, 2014


Marsh, a global leader in insurance broking and risk management, today announced that its Marsh Analytics Platform (MAP), a comprehensive solution enabling clients to quantify and manage risk financing through a notable combination of data, analytics, and technology, is now backed by an industry leading proprietary global loss database, a trained global team of sales professionals, and hundreds of devices with the industry’s only mobile content-delivery platform, known as iMAP.
Sign-up for - Marsh Executes on Commitment to Rapid Expansion of Marsh Analytics Platform investment picks
2014/11/3
SHENZHEN, China , Nov.
Sign-up for 2014/11/3 - Nam Tai Property Inc. Reports Q3 2014 Results investment picks
New ViewPoint RTX Correction Service Delivers Better-Than 1 Meter Position Accuracy LAS VEGAS , Nov.
Sign-up for - Trimble Announces Trimble Leap Submeter GNSS Device and Terrain Navigator Pro for High-Accuracy Data Collection using Trimble RTX Technology investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0976522001&sourceType=1 http://media3.marketwire.com/logos/20130306-RESPBIO.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for - Response Biomedical Corp. Provides Update on Term Loan investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0976710001&sourceType=1 http://media3.marketwire.com/docs/orvanalogoLG.jpg TORONTO, ONTARIO --
Sign-up for - Orvana to Attend Precious Metals Summit, Zurich-November 4-5, 2014 investment picks
AGOURA HILLS, Calif.
Sign-up for - American Homes 4 Rent Announces Distributions investment picks
CNOOC Limited Announces First Oil from Golden Eagle Area Development Canada NewsWire HONG KONG , Nov.
Sign-up for - CNOOC Limited Announces First Oil from Golden Eagle Area Development investment picks
2014/11/3
- Third quarter 2014 net income increased 40 percent from the previous year to $19.6 million and $0.72 per share or $20.1 million and $0.74 per share, excluding pension settlement charges.
Sign-up for 2014/11/3 - ArcBest Corporation Announces Third Quarter 2014 Results investment picks
2014/11/3
It’s a mobile office.
Sign-up for 2014/11/3 - Room Key 2.0 – Key Card Optional investment picks
2014/11/3
By Cris Larano MANILA--Metropolitan Bank & Trust Co.
Sign-up for 2014/11/3 - Metrobank Offers Tranche of Seven-Year Deposit Certificates investment picks
Callidus Capital Corporation to Host Fiscal 2014 Third Quarter Results Conference Call Canada NewsWire TORONTO , Nov.
Sign-up for - Callidus Capital Corporation to Host Fiscal 2014 Third Quarter Results Conference Call investment picks
2014/11/3
Tallgrass Pony Express Pipeline, LLC (“Pony Express”) announced today that it has commenced a binding open season for the previously announced expansion of its crude oil pipeline system.
Sign-up for 2014/11/3 - Tallgrass Pony Express Pipeline Announces Binding Open Season for Crude Oil Pipeline Expansion investment picks
Getty Realty Corp.
Sign-up for - Getty Realty Corp. Announces Results for the Third Quarter 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025378-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/3/11G025378/Brown_and_Brown-399424616100.jpeg DAYTONA BEACH, FL--(Marketwired - November 03, 2014) - Brown & Brown, Inc. (the "Company") (NYSE: BRO) corrected certain errors contained in a press release issued by Zacks Investment Research, Inc. and resulting media reports that incorrectly reported that the Company failed to meet Zacks Investment Research's consensus estimate of earnings per share following the Company's October 17, 2014 press release announcing its results of operations for the third quarter ended September 30, 2014.
Sign-up for - Brown & Brown, Inc. Corrects Error in Third-Party Analyst Reports investment picks
NORCROSS, Ga., Nov.
Sign-up for - RockTenn Reports Fourth Quarter Fiscal 2014 Earnings investment picks
2014/11/3
CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that it has received U.S.$515 million of commitments from banks that have agreed to join the credit agreement entered into on September 30, 2014 (the “Credit Agreement”). Following the completion of customary closing conditions, the banks that provided the new commitments will accede the Credit Agreement as additional lenders, increasing the total amount of the Credit Agreement from U.S.$1.35 billion to U.S.$1.87 billion.
Sign-up for 2014/11/3 - CEMEX Increases New Bank Loan to U.S.$1.87 Billion and Successfully Concludes Amendment to Facilities Agreement investment picks
Umpqua Holdings Corporation (NASDAQ:UMPQ) (the “Company”) announced today the commencement of a secondary public offering of 31,190,716 shares of the Company’s common stock, including 28,300,720 shares by certain funds affiliated with Thomas H.
Sign-up for - Umpqua Holdings Corporation Announces Secondary Offering of Shares investment picks
ST. LOUIS, Nov.
Sign-up for - Post Holdings Completes Acquisition of American Blanching Company investment picks
Albany International Corp.
Sign-up for - Albany International Reports Third-Quarter Results investment picks
2014/11/3
By Anthony Harrup MEXICO CITY--The Mexican government on Monday awarded a $3.7 billion project to build a bullet train in central Mexico to a Chinese-led consortium, saying that the single bid met the project's technical and financial requirements.
Sign-up for 2014/11/3 - China-led Consortium Makes Sole and Winning Bid for Mexican Bullet Train investment picks
http://media.marketwire.com/attachments/201302/130232_logo-R-red-on-white.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155964&ProfileId=051205&sourceType=1 MALVERN, PA --
Sign-up for - CubeSmart's Credit Rating Upgraded to BBB by Standard & Poor's investment picks
NEW YORK, Nov.
Sign-up for - StoneCastle Financial Corp. Announces Follow-On Offering investment picks
Clinical programs advance on multiple fronts, with trial initiation, trial enrollment, data and IP milestones achieved and anticipated Commercial strategy reinforced with product acquisition and upcoming commercial launch Abstral ® (fentanyl) sublingual tablet net revenue was $1.6 million in Q3 2014 and $6.1 million to date this year, with reiterated guidance of $8-$10 million for the full year 2014 Zuplenz ® (ondansetron) Oral Soluble Film U.S. rights licensed; launch expected in Q1 2015 Conference call scheduled for 5:00 pm E.T. today with details below PORTLAND, Ore., Nov.
Sign-up for - Galena Biopharma Reports Third Quarter 2014 Results investment picks
SAN DIEGO , Nov.
Sign-up for - Halozyme to Host Third Quarter 2014 Financial Results Conference Call investment picks
Revenue Increased 7.7% to $229.7 Million GAAP EPS was $0.30 Adjusted EPS Increased 16% to $0.76 Operating Cash Flow was $31.1 Million PLAINSBORO, N.J., Nov.
Sign-up for - Integra LifeSciences Reports Third Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201302/125526_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155909&ProfileId=051205&sourceType=1 SAN DIEGO, CA --
Sign-up for - NuVasive to Host Investor Morning on November 13, 2014 investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: - Marsh Executes on Commitment to Rapid Expansion of Marsh Analytics Platform to - NuVasive to Host Investor Morning on November 13, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent